Takeda Pharmaceutical Co Adr (TAK)

Sep 30, 2026

TKDA Stock Price and Chart — HAN:TKDA - TradingView

Sep 30, 2026

Sep 29, 2026

TKDA Forecast — Price Target — Prediction for 2027 - TradingView

Sep 29, 2026

Sep 29, 2026

Book value per share of Takeda Pharmaceutical Co. Ltd. Sponsored ADR – HAN:TKDA - TradingView

Sep 29, 2026

Sep 29, 2026

ETFs Investing in Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stocks - TradingView

Sep 29, 2026

Sep 29, 2026

KROS Begins Dosing in Phase II Study With Rinvatercept in DMD - Zacks Investment Research

Sep 29, 2026

Sep 25, 2026

Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - GlobeNewswire Inc.

Sep 25, 2026

Sep 24, 2026

Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history - Yahoo Finance UK

Sep 24, 2026

Sep 23, 2026

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history - Yahoo Finance Singapore

Sep 23, 2026

Sep 23, 2026

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

Sep 19, 2026

Dr Reddy's Laboratories stock gains attention on QDENGA vaccine deal - ad-hoc-news.de

Sep 19, 2026

Sep 18, 2026

NY stocks mixed, Dow falls for first time in 3 days on rate hike concerns - finance.biggo.com

Sep 18, 2026

Sep 12, 2026

SGIOY Stock Price, Quote & News - Syfe

Sep 12, 2026

Aug 31, 2026

Organon & Co. (OGN) Peer Comparison – Compare with Others - Value Research

Aug 31, 2026

Aug 29, 2026

Teva Pharma Industries Ltd ADR (TEVA) Peer Comparison – Compare with Others - Value Research

Aug 29, 2026

Aug 29, 2026

Protagonist Therapeutics receives FDA approval for polycythemia vera drug By Investing.com - Investing.com India

Aug 29, 2026

Aug 28, 2026

Protagonist Therapeutics receives FDA approval for polycythemia vera drug - Investing.com

Aug 28, 2026

Aug 28, 2026

Analysts Offer Insights on Healthcare Companies: Sysmex (OtherSSMXF) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail

Aug 28, 2026

Aug 18, 2026

Takeda Pharmaceutical Co Ltd (ADR) (TAK) News, Articles, Events & Latest Updates - Stocktwits

Aug 18, 2026

Aug 14, 2026

Takeda (NYSE:TAK) Climbs Into Focus On Sleep Disorder Milestone - Kalkine Media

Aug 14, 2026

Aug 07, 2026

Takeda (TAK) Q1 2026 Earnings Call Transcript - theglobeandmail.com

Aug 07, 2026

Aug 05, 2026

US FDA approves Takeda’s sleep disorder pill By Reuters - Investing.com

Aug 05, 2026

Aug 01, 2026

Takeda Pharmaceutical (TAK) Slips 0.93% to $17.09 as Defensive Sector Shows Mixed ToneDealer Positioning - dars.gov.et

Aug 01, 2026

Jul 31, 2026

Corporate Lobbying Dashboard - Quiver Quantitative

Jul 31, 2026

Jul 30, 2026

Murata ADR Surges 15%, SoftBank Group Jumps 7% as Semiconductor, Tech Stocks See Short-Covering - finance.biggo.com

Jul 30, 2026

Jul 26, 2026

Takeda Pharmaceutical (TAK) Gains 2.5%; Approaches Key Resistance LevelStrangle Setup - dars.gov.et

Jul 26, 2026

Jul 18, 2026

TAK: Takeda Pharmaceutical Co Ltd (ADR) Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 18, 2026

Jul 13, 2026

Takeda invests $30M to build Indonesian plasma ecosystem - grafa.com

Jul 13, 2026

Jul 13, 2026

Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com - Investing.com Canada

Jul 13, 2026

Jul 08, 2026

6 High-Yield International Dividend Stocks Analysts Love - Forbes

Jul 08, 2026

Jul 02, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 02, 2026

Jul 01, 2026

India Celiac Disease Treatment Market Size & Outlook, 2033 - grandviewresearch.com

Jul 01, 2026

Jun 28, 2026

0A87 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 28, 2026

Jun 27, 2026

TAK-755 from Takeda Pharmaceutical Co.enzyme replacement for a rare bleeding disorder - Ad-hoc-news.de

Jun 27, 2026

Jun 27, 2026

Takeda Pharmaceutical Co. Ltd. Sponsored ADR Actuals & Estimates (LS:A1CWZF) - TradingView

Jun 27, 2026

Jun 26, 2026

A1CWZF Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026